XML 35 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net loss $ (17,051) $ (108,779)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation, amortization and accretion 8,815 10,146
Impairment expense 5,705 75,458
Inventory write-down 2,351 2,186
Stock-based compensation expense 6,046 5,248
Gain on derivative warrant liability (4,793) (1,605)
Gain from contingent consideration (969) (1,655)
Amortization of senior debt (premium) discount 559 (126)
Shares issuance related to milestone payment   1,425
Gain on debt extinguishment   (193)
Other noncash adjustments 7 (65)
Changes in operating assets and liabilities:    
Accounts receivable (7,153) 6,533
Inventory (3,609) 1,299
Prepaid expenses and other current assets (914) 2,228
Accounts payable and other 2,384 (7,681)
Accrued liabilities 3,605 (13,292)
Other operating assets and liabilities, net (111) 50
Net cash used in operating activities (5,129) (28,823)
Investing Activities    
Contingent consideration payment (5) (3,178)
Other investing activities (112) (70)
Net cash used in investing activities (117) (3,248)
Financing Activities    
Net proceeds from issuance of stock 15,575 11,694
Payment made to fixed payment arrangement (4,266) (4,409)
Net payments made on short-term line of credit (2,250) (4,121)
Payments made to borrowings (96) (16,101)
Proceeds from borrowings   15,000
Payment for debt issuance costs (92) (526)
Other financing activities   (7)
Net cash provided by financing activities 8,871 1,530
Net change in cash and cash equivalents 3,625 (30,541)
Cash and cash equivalents at beginning of period 19,360 49,901
Cash and cash equivalents at end of period 22,985 19,360
Supplemental cash flow data    
Cash paid for interest 3,812 3,148
Non-cash investing and financing activities:    
Other noncash investing and financing activities $ 147 $ 54